TopFunds

CME Group Inc.

NASDAQ: CME

Stock price

293.87 USD

(+0%) TODAY

Financial - Data & Stock ExchangesInvestable Universe
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3.7
4.5
11.9
5.7
5.9
5.9
7.3
7.4
8.9
9.7
11.2
11.7%
02Free cash flow per share
4.1
4.8
5.2
6.8
6.8
7
6.3
8.3
9.4
10
11.6
10.9%
03Dividends per share
4.9
5.6
6.1
4.6
5.5
5.9
6.9
8.5
9.6
10.4
5
0.2%
04Dividends payout, %
1.1%
1.2%
49.1%
1.1%
80.1%
1%
83%
97.9%
1%
1%
97.3%
56.9%
PROFIT AND LOSS STATEMENT
05Revenue
3,327
3,595
3,645
4,309
4,868
4,884
4,690
5,019
5,579
6,130
6,521
7%
06% Change
-
-
-
-
-
-
-
-
-
-
-
7%
07Cost of revenue
(581.5)
(543.2)
(563.9)
(672.2)
(898.7)
(856.5)
(837)
(753.1)
(828.6)
(850.3)
(907)
4.6%
08Gross profit
2,745
3,052
3,081
3,637
3,969
4,027
3,853
4,266
4,750
5,280
5,614
7.4%
09% Margin
82.5%
84.9%
84.5%
84.4%
81.5%
82.5%
82.2%
85%
85.2%
86.1%
86.1%
84.1% A
10Operating expenses
(756.6)
(824.7)
(745.9)
(1,030)
(1,382)
(1,390)
(1,208)
(1,250)
(1,315)
(1,348)
(1,384)
6.2%
11% of Revenue
(22.7)%
(22.9)%
(20.5)%
(23.9)%
(28.4)%
(28.5)%
(25.8)%
(24.9)%
(23.6)%
(22)%
(21.2)%
(24)% A
12Operating Income
1,989
2,201
2,311
2,608
2,588
2,637
2,645
3,016
3,436
3,932
4,230
7.8%
13Income tax expense
(709.8)
(753.5)
(1,537)
(814.1)
(573.8)
(615.7)
(736.7)
(799.3)
(927.4)
(1,016)
(1,273)
6%
14Net Income
1,247
1,534
4,063
1,962
2,117
2,105
2,636
2,691
3,226
3,526
4,044
12.5%
15% Margin
37.5%
42.7%
111.5%
45.5%
43.5%
43.1%
56.2%
53.6%
57.8%
57.5%
62%
55.5% A
16Shares Outstanding
337.9
339
340.2
343.7
358.2
358.5
358.9
359.2
359.5
359.9
360.2
0.6%
17EPS Basic
3.7
4.6
12
5.7
5.9
5.9
7.3
7.4
8.9
9.7
11.2
11.7%
18EPS Diluted
3.7
4.5
11.9
5.7
5.9
5.9
7.3
7.4
8.9
9.7
11.2
11.7%
19EBITDA
2,303
2,636
2,852
3,184
3,341
3,353
3,926
4,016
4,666
5,039
5,776
9.6%
% Margin
69.2%
73.3%
78.3%
73.9%
68.6%
68.7%
83.7%
80%
83.6%
82.2%
88.6%
77.3% A
20Net Interest Income (expense)
(117.4)
(123.5)
(117)
(157.7)
(178)
(166.2)
(166.9)
(162.7)
(159.4)
(160.9)
(129.7)
1%
21Net Debt / EBITDA
15.7
14.4
15.6
1
0.7
0.5
0.2
0.2
0.1
0.1
(0.2)
4.4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,693
1,869
1,904
1,375
1,551
1,633
2,835
2,720
2,912
2,892
4,417
10.1%
23Short-term investments
72.5
83.3
90.1
72.9
83.2
100.9
115
96
111.7
113.2
125
5.6%
24Accounts receivable
357.8
364.4
359.7
553.3
491.8
461.3
434.5
483.2
535.6
573.1
639.2
6%
25Other current assets
35,782
37,715
44,553
39,886
37,441
87,089
158,377
135,779
91,331
99,455
160,178
16.2%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
37,905
40,032
46,907
41,887
39,568
89,284
161,762
139,078
94,890
103,034
165,359
15.9%
Non-Current Assets
28Net property, plant & equipment
491.7
425.2
399.7
448.7
544
579.2
505.3
455.5
409.5
386.2
362.7
(3)%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
-
-
30Other non-current assets
28,963
28,913
28,485
35,140
35,104
34,797
34,513
34,642
34,406
34,027
32,702
1.2%
31Total Non-Current Assets
29,455
29,338
28,885
35,589
35,648
35,376
35,019
35,097
34,816
34,414
33,065
1.2%
Total Assets
67,359
69,369
75,791
77,476
75,215
124,660
196,780
174,176
129,706
137,447
198,424
11.4%
LIABILITIES
Current Liabilities
32Accounts payable
28.7
26.2
31.3
116
61.9
69.3
48.8
121.4
90.6
79.9
71.8
9.6%
33Short-term debt
35,553
37,543
44,185
574.2
-
-
749.4
16
-
749.8
-
-
34Other current liabilities
1,243
1,377
1,456
40,582
38,461
88,129
159,600
137,550
93,326
101,484
160,225
62.6%
35Total Current Liabilities
36,825
38,946
45,673
41,273
38,523
88,198
160,398
137,688
93,417
102,314
160,297
15.9%
Non-Current Liabilities
36Long-term debt
2,229
2,231
2,233
3,827
3,743
3,444
2,696
3,422
3,425
2,678
3,422
4.4%
37Other non-current liabilities
7,754
7,852
5,473
6,411
6,790
6,666
6,287
6,187
6,126
5,968
5,977
(2.6)%
38Total Non-Current Liabilities
9,983
10,083
7,707
10,238
10,534
10,110
8,983
9,610
9,551
8,646
9,399
(0.6)%
39Total Liabilities
46,808
49,029
53,379
51,510
49,056
98,308
169,381
147,297
102,968
110,960
169,696
13.8%
SHAREHOLDERS` EQUITY
40Common stock
3.4
3.4
3.4
3.6
3.6
3.6
3.6
3.6
3.6
3.6
3.6
0.6%
41Retained earnings / (deficit)
2,908
2,525
4,497
4,855
5,009
4,996
5,152
4,747
4,455
4,186
6,433
8.3%
42Accumulated other comprehensive income / (loss)
(80.8)
(14.1)
14.3
5.3
3.4
134.9
53.5
(133.3)
(55.6)
(105.5)
81.9
-
43Noncontrolling interests
-
-
-
46.8
30.4
31.6
-
-
-
-
-
-
44Total shareholders' equity
20,552
20,341
22,412
25,965
26,159
26,352
27,399
26,879
26,738
26,487
28,728
3.4%
45Total Liabilities and shareholders' Equity
67,359
69,369
75,791
77,476
75,215
124,660
196,780
174,176
129,706
137,447
198,424
11.4%
46Total Debt
37,782
39,774
46,418
4,401
3,743
3,444
3,445
3,438
3,425
3,428
3,422
(21.4)%
47Net Debt
36,090
37,905
44,515
3,027
2,192
1,811
610.2
718.3
513.4
535.6
(994.6)
-
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,247
1,534
4,063
1,962
2,117
2,105
2,636
2,691
3,226
3,526
4,044
12.5%
49Depreciation & amortization
228.6
225.3
208.5
248.7
473.3
464.4
385.4
362.6
352.6
336.8
330.9
3.8%
50Share-based compensation expense
60.8
66.2
58
96.5
73.1
96
75.2
84.3
82.9
89.5
94.8
4.5%
51Changes in working capital and other assets
(21.1)
(109.6)
(2,490)
133.4
9.9
50
(694.6)
(81.9)
(207.9)
(261.6)
(193)
24.8%
52Net cash flows from operating activities
1,515
1,716
1,840
2,441
2,673
2,716
2,402
3,056
3,454
3,691
4,277
10.9%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(114.2)
(91.8)
(81.9)
(116.7)
(245.6)
(197.5)
(127.2)
(89.7)
(76.4)
(94)
(83.5)
(3.1)%
54Purchases of investments / marketable securities
(35.3)
(45.9)
(3)
(10)
(15.4)
(11.1)
(7.8)
(4.4)
(4.1)
(4.5)
(6)
(16.2)%
55Proceeds from maturities of marketable securities
184.1
191.7
266.1
11.8
18.8
12.3
9.4
6.3
5.9
6
7.9
(27)%
56Other investing activities
(16.7)
(0.3)
(1.3)
(1,775)
89.6
20.8
184
(402)
95.5
9.9
1,580
-
57Net cash flows from investing activities
17.9
53.7
179.9
(1,890)
(152.6)
(175.5)
58.4
(489.8)
20.9
(82.6)
1,499
55.7%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
64
51.8
36.7
398.4
-
(41.4)
965
(24.8)
(21.4)
(33)
(266.1)
-
59Dividends paid, net
(1,343)
(1,787)
(1,994)
(2,150)
(1,696)
(2,110)
(2,189)
(2,634)
(3,236)
(3,584)
(3,933)
11.3%
60Debt issuance (repayments), net
70.7
-
-
1,119
(661.7)
(304.6)
-
(15.2)
(16.4)
-
(9.4)
-
61Other financing activities
2
141.7
(28.5)
(447.9)
16.8
(2.2)
71,133
(22,708)
(45,066)
8,694
60,718
180.7%
62Net cash flows from financing activities
(1,207)
(1,594)
(1,985)
(1,080)
(2,341)
(2,458)
69,909
(25,382)
(48,339)
5,077
56,510
-
63Increase (decrease) in cash and cash equivalents
326.5
176
35
(528.8)
179.4
81.9
72,370
(22,816)
(44,865)
8,684
62,285
69.1%
64Cash and equivalents, ending balance
1,693
1,869
1,904
1,377
1,557
1,639
160,790
137,974
93,110
101,794
164,080
58%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,401
1,624
1,759
2,324
2,427
2,518
2,275
2,966
3,377
3,597
4,194
11.6%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

CME Group Inc. (CME) financial statements and performance

Explore CME Group Inc. (CME) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.